Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2015-08-26

FDA Approved: EDURANT — Supplemental Application (Janssen Products, LP)

View source ↗

Summary

The FDA approved Janssen's supplemental application for EDURANT (rilpivirine hydrochloride), updating the labeling for the product as requested in the supplemen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Edurant (rilpivirine)

Snippet

SUPPL AP for EDURANT (RILPIVIRINE HYDROCHLORIDE)